Top Markets
#1 Verus Coin Verus Coin +22.44%
#2 Ontology Gas Ontology Gas +19.53%
#3 Status Status +17.90%
#4 ETHGas ETHGas +15.70%
#5 Geodnet Geodnet +13.21%
#6 Derive Derive +12.82%
#7 Curve DAO Curve DAO +11.62%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +9.94%
#9 Anvil Anvil +9.76%
#10 The Black Bull The Black Bull +9.10%
Coin of the day
Verus Coin Verus Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Greenyn Biotechnology Co., Ltd Greenyn Biotechnology Co., Ltd

Greenyn Biotechnology Co., Ltd

6846
Rang in Aktien #25419
Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary... Greenyn Biotechnology Co., Ltd is an enterprise specializing in dietary supplements, dedicated to the development, production, and worldwide distribution of health-enhancing products. Their product portfolio includes a range of proprietary active ingredients. These feature notable components such as Insumate, derived from bitter melon extract; Antromax, which utilizes antrodia cinnamomea; and the Zymologist 101 Phyto fermented drink. Beyond individual ingredients, Greenyn provides an extensive selection of functional product series catering to a diverse array of health and wellness needs. These encompass solutions for youth and beauty, digestive and brain health, overall body regulation, throat care, hair care, vision support, and various lifestyle enhancement formulas. Additional ranges include joint health, general nutritional and energy supplementation, immune modulation, low-burden options, sleep assistance, body contouring, circulatory support, specific formulas for men's vitality and women's intimate health, and dedicated products for mature women. Moreover, the company extends its expertise through various services, including custom product development, Original Design Manufacturing (ODM), dosage form optimization, and application support. Established in 2012, the firm's operations are headquartered in Taichung, Taiwan.
Aktienkurs
$1.84
Marktkapitalisierung
$49.75M
Veränderung (1 Tag)
0.87%
Veränderung (1 Jahr)
-24.88%
Land
TW
Handel Greenyn Biotechnology Co., Ltd (6846)

Kategorie

Healthcare
Gewinn für Greenyn Biotechnology Co., Ltd (6846)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von Greenyn Biotechnology Co., Ltd betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Greenyn Biotechnology Co., Ltd von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US